All investigators on sponsored research, whether internally or externally funded, are required to complete a financial disclosure statement annually. You may access the combined OSPA and UKHC questionnaire in COI-Smart using your LinkBlue ID and password at the COI-Smart website.

If you prefer to access COI-Smart through myUK, the COI-Smart link can be found under the Enterprise Services tab: select “Workflow” in the Enterprise Services tab and then “Financial Disclosure.”

As a reminder, your participation is mandatory. Please note that your questionnaire is due by March 31, 2022. For questions or technical support, please contact Dr. Emily Bradford ([email protected]).

Wednesday March 23, 2022 | 12:00 - 1:00PM

Presenters Include 2021-2022 Research Scholars:

• Adebola Adegboyega, Assistant Professor, Nursing
• Jean Fry, Assistant Professor, Athletic Training and Clinical Nutrition
• Joseph Benitez, Assistant Professor, Health Policy and Management
• Cetewayo Rashid, Assistant Professor, Pharmacology and Nutritional Sciences
• Michael Samaan, Assistant Professor, Kinesiology and Health Promotion
• Lauren Whitehurst, Assistant Professor, Psychology

• Nancy Schoenberg, Associate Vice President for Research
• Kevin Pearson, Director of Inclusive Research Initiatives, College of Medicine

This is part of the VPR Lunch & Learn series. Registration is not required.

Only available by Zoom: https://uky.zoom.us/j/9251686420

Agency: The Patient-Centered Outcomes Research Institute (PCORI)

Description: The Patient-Centered Outcomes Research Institute (PCORI) plans to award up to $25 million in fiscal year 2022 as part of the Eugene Washington PCORI Engagement Awards. These awards are for research support projects. This program does not fund research studies.

The Eugene Washington PCORI Engagement Awards support projects that encourage active, meaningful involvement of patients, caregivers, clinicians, and other healthcare stakeholders as integral members of the patient-centered outcomes research/comparative clinical effectiveness research (PCOR/CER) enterprise.

The Engagement Awards program is now accepting Letters of Intent (LOIs) for the Engagement Award: Stakeholder Convening Support funding opportunity. This opportunity aims to support projects that include multi-stakeholder convenings, meetings, and conferences that align with PCORI’s mission and facilitate expansion of PCOR/CER through collaboration around such efforts.

Closing Date: April 4, 2022

Agency: The Patient-Centered Outcomes Research Institute (PCORI)

Description: With this PCORI Funding Announcement (PFA), PCORI aims to fund studies that address high-priority methodological gaps in patient-centered outcomes research (PCOR) and clinical comparative effectiveness research (CER).

PCORI seeks to fund projects that address important methodological gaps and lead to improvements in the strength and quality of evidence generated by PCOR/CER studies

For the 2022 Methods PFA, PCORI has identified the following areas as programmatic priorities:

• Methods to Improve the Use of Artificial Intelligence (AI) and Machine Learning (ML) in Clinical Research
• Methods to Improve Study Design
• Methods to Support Data Research Networks
• Methods Related to Ethical and Human Subjects Protections Issues in PCOR/CER

Letter of Intent Deadlines: Cycle 1: February 8, 2022, Cycle 2: June 1, 2022, Cycle 3: October 4, 2022

Full Application Deadlines: Cycle 1: May 3, 2022, Cycle 2: August 31, 2022, Cycle 3: January 10, 2023

Agency: The Patient-Centered Outcomes Research Institute (PCORI)

Description: PCORI is pleased to announce the simplification and expansion of two longstanding funding opportunities known as the Broad PCORI Funding Announcement (PFA) and Pragmatic Clinical Studies (PCS) PFA. Starting in Cycle 1, 2022, PCORI will combine these two PFAs into a single PFA entitled the Broad Pragmatic Studies (BPS) PFA. This new PFA covers the following four priority areas: Addressing Disparities; Assessment of Prevention, Diagnosis, and Treatment Options; Communication and Dissemination Research; and Improving Healthcare Systems. These broad areas encompass the patient-centered comparative clinical effectiveness Research (CER) that PCORI has long supported.

Letter of Intent Due Dates: Cycle 1: February 8, 2022, Cycle 2: June 1, 2022, Cycle 3: October 4, 2022

Full Application Due Dates: Cycle 1: May 3, 2022, Cycle 2: August 31, 2022,Cycle 3: January 10, 2023

Agency: Department of Justice (DOJ) - National Institute of Justice (NIJ)

Description: This solicitation has four primary objectives: (1) conduct research to inform terrorism prevention efforts; (2) conduct research on disengagement, deradicalization, reintegration of radicalized individuals and/or violent extremists; (3) evaluate programs and practices to prevent terrorism; and (4) conduct research on the spread of extremist ideologies (specifically the use of mis-, dis-, and mal-information) and how to counter extremist narratives. The deliverables from this solicitation will consist of published works that speak to these objectives. Applicants must apply to one of the four Research Topics listed. In their applications, applicants must explicitly state which Research Topic they are requesting funding consideration under. Applications for other than one of these four topics will not be considered.

Topic #1: Research to Inform Terrorism Prevention Efforts

Topic #2: Research on Disengagement, Deradicalization, and Reintegration

Topic #3: Evaluations of Programs and Practices to Prevent Terrorism

Topic #4: Mis-, Dis-, and Mal-information

Announcement Number: O-NIJ-2022-171193

Closing Date: April 25, 2022 

Agency: National Institute on Drug Abuse (NIDA)

Purpose: This Notice encourages research projects that 1) leverage data science to provide actionable insights for substance use prevention and treatment, 2) shorten the time between data capture and data availability so that data are available real-time or near real-time, and 3) explore methods and tools that may allow for faster or better localized responses for substance use treatment and prevention. Priority will be given to projects that emphasize the use of existing data streams (e.g., electronic health records, syndromic surveillance, claims data, registry data, pharmacy dispensing, social media, and mortality records).

Collaborations among multiple disciplines are encouraged for this Notice. Priority will be given to applications that demonstrate the involvement and support of community-based stakeholders and other end-users (e.g., clinicians, patients, parents, public health professionals, patient representatives) along the research continuum.

Related Announcements

• PA-20-185 - NIH Research Project Grant (Parent R01 Clinical Trial Not Allowed)
• PA-20-183 - NIH Research Project Grant (Parent R01 Clinical Trial Required)
• PA-20-200 - NIH Small Research Grant Program (Parent R03 Clinical Trial Not Allowed)
• PA-20-195 - NIH Exploratory/Developmental Research Grant Program (Parent R21 Clinical Trial Not Allowed)
• PA-20-194 - NIH Exploratory/Developmental Research Grant Program (Parent R21 Clinical Trial Required)
• PA-20-272 - Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp - Clinical Trial Optional)
• PA-20-022 - Research Supplements to Promote Diversity in Health-Related Research (Admin Supp - Clinical Trial Not Allowed)

First Available Due Date: June 05, 2022

Agency: Agency for Healthcare Research and Quality (AHRQ)

Purpose: This Special Emphasis Notice (SEN) informs the research community that AHRQ is interested in receiving health services research grant applications to advance the science of primary care. We will use our standing R01, R18, and R03 mechanism to fund primary care focused health services research.

Revitalizing the Nation’s primary care system is critical to achieving AHRQ’s mission of improving the quality, safety, accessibility, equity and affordability of health care. For years, AHRQ has made significant investments in research to understand how to improve primary care—including investing in primary care training and practice-based research networks, integrating behavioral health and primary care, and evaluating the patient-centered medical home and the costs of primary care transformation AHRQ’s continued dedication to advancing the field of primary care research includes the expansion of the capacity of the National Center for Excellence in Primary Care Research to promote primary care research.

Related Announcements:

• PA-18-793 - AHRQ Health Services Research Demonstration and Dissemination Grants (R18)
• PA-18-794 - AHRQ Small Research Grant Program (R03)
• PA-18-795 - AHRQ Health Services Research Projects (R01)
• PA-21-202 - AHRQ/PCORI Learning Health System Small Grant Pilot Program
• NOT-HS-16-011 - Innovative Research in Primary Care
• NOT-HS-16-013 - Optimizing Care for People Living with Multiple Chronic Conditions through the Development of Enhanced Care Planning

Agency: National Institute on Aging (NIA)

Release Date: March 9, 2022

Purpose: This Request for Information invites comments and suggestions for the National Institute on Aging to consider as it explores strategies relevant to, challenges inherent in, and the potential benefits of capacity-building for community-based research networks, with the goal of engaging a wider, more diverse group of participants in Alzheimer’s disease (AD) and AD-related dementias (ADRD) clinical trials. Specifically, NIA seeks insights that will enable us to enhance sustainable engagement with a wide variety of participants, including people from underserved groups, which includes rural communities, people of various races and ethnicities, minority health and health disparity groups, and older people of diverse physical and neurological abilities, in AD/ADRD clinical trials. NIA solicits information on both the current capacity, and the additional resources needed, to leverage, augment, and/or create new configurations of community-based research network(s) to engage in the conduct of AD/ADRD clinical trials.